CIIT vs EW · rev $9.3M vs P/E 47, rev $1.39B
Tianci International, Inc. Common Stock (CIIT) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Tianci International, Inc. Common Stock (CIIT) is a integrated freight & logistics company listed on NASDAQ.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CIIT revenue for 2025-07-31 was $9.3M. Net income was -$2.7M. Revenue was up 7.7% from 2024-07-31 to 2025-07-31. CIIT currently screens at market cap $2.1M.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CIIT currently screens at market cap $2.1M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CIIT and EW stock pages for the full models.
Not investment advice.